XML 50 R39.htm IDEA: XBRL DOCUMENT
v3.26.1

Loss Per Common Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares | 3 Months Ended
--- | ---
Mar. 31, 2026 | Mar. 31, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Antidilutive securities (in shares) | 97,048,057 | 12,681,196
October 2024 Common Warrants |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Antidilutive securities (in shares) | 2,398,414 | 2,398,414
March 2025 Common Warrants |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Antidilutive securities (in shares) | 8,316,882 | 8,316,882
July 2025 Common Warrants |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Antidilutive securities (in shares) | 3,076,921 | 0
January 2026 Series A Common Warrants |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Antidilutive securities (in shares) | 26,926,675 | 0
January 2026 Series B Common Warrants |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Antidilutive securities (in shares) | 26,926,675 | 0
January 2026 Series C Common Warrants |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Antidilutive securities (in shares) | 26,926,675 | 0
Stock Options |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Antidilutive securities (in shares) | 2,327,465 | 1,595,263
Restricted Stock |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Antidilutive securities (in shares) | 0 | 40,137
Restricted Stock Units (RSUs) |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Antidilutive securities (in shares) | 148,350 | 330,500

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cris_October2024CommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cris_March2025CommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cris_July2025CommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cris_January2026SeriesACommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cris_January2026SeriesBCommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cris_January2026SeriesCCommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |